SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...

Over the past two decades, management of pain in patients with systemic lupus erythematosus (SLE) has come to rely less on higher-risk therapies like opioids, although prescribing intensity remains ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. Systemic sclerosis (SSc) or scleroderma is another rheumatic autoimmune disease that ...

SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...

When people with systemic lupus erythematosus (SLE) actively participate in shared decision-making (SDM) about their disease with their doctors’, trust is likely to increase. A new study found that ...

Please provide your email address to receive an email when new articles are posted on . The acceptable threshold for glucocorticoid use for lupus maintenance therapy should be 5 mg per day prednisone ...

The SLECRISK tool for predicting cardiovascular disease among patients with systemic lupus erythematosus produces more accurate predictions compared with the American College of Cardiology/American ...

Almost 90% of a cohort of patients with systemic lupus erythematosus reported experiencing depression or depressive symptoms ...

A new study found peer-mentoring interventions on self-reported disease activity, symptom severity, and flare frequency among adult African American women with systemic lupus erythematosus (SLE) may ...